IP Library Granted Patent US 7,741,367
Granted Patent B2
US 7,741,367 · App. 11/672,223 · Granted Jun 22, 2010

Method of using abscisic acid to treat diseases and disorders

Assignee: Virginia Tech Intellectual Properties, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,367
App. No.
11/672,223
Granted
Jun 22, 2010
Kind
B2
Abstract

The present invention provides compositions and methods for treating and/or preventing diseases and disorders associated with expression of PPAR γ and/or infiltration of macrophages into skeletal muscle tissue and/or white adipose tissue. The method treats such diseases and disorders with abscisic acid (ABA). Exemplary diseases and disorders include diabetes, including type 2 diabetes, prediabetes, glucose intolerance insulin resistance, and diseases and disorders involving the immune system, such as inflammation, including obesity-related inflammation, inflammatory bowel disease, type 1 diabetes, multiple sclerosis, allergies, asthma, cardiovascular disease, and arthritis.

Claims (8)

1. A method of increasing insulin sensitivity and improving obesity-induced inflammation in a mammal, the method comprising administering to the mammal a composition consisting essentially of:

one or more compounds selected from: abscisic acid (ABA) in its free acid form, esters thereof, pharmaceutically suitable salts thereof, metabolites thereof, structurally related compounds thereof, and analogs thereof, in amounts that are sufficient to alter the expression or activity of PPAR γ in a cell of the mammal; and

a carrier that has substantially no effect on the expression or activity of PPAR γ in a cell of the mammal.

2. The method of claim 1 , wherein the carrier is a pharmaceutical carrier.

3. The method of claim 1 , wherein the carrier is a nutritional supplement, functional food, or dietary aid.

4. The method of claim 1 , wherein the purity of the substantially pure preparation is greater than about 95%.

5. The method of claim 1 , wherein the one or more compounds is abscisic acid in its free acid form.

6. The method of claim 1 , wherein the abscisic acid in its free acid form is chemically synthesized.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: BASSAGANYA-RIERA, JOSEP; GURI, AMIR J.; HONTECILLAS, RAQUEL
To: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
Reel/Frame 024896/0455 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
To: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Reel/Frame 024896/0828 →
Continuity (3)
Provisional Application 6077103300 · Feb 8, 2006
Provisional Application 6082172000 · Aug 8, 2006
Related Publication 20070184060A1 · Aug 9, 2007